- Vaccines, offering immunological protection against a wide range of infectious diseases, remain essential components of public health programs across both developed and developing regions due to their proven effectiveness in disease prevention, cost efficiency, and herd immunity support
- The growing demand for vaccines is primarily fueled by increased governmental immunization initiatives, rising global disease burden, and technological advancements in vaccine delivery systems, such as mRNA platforms and combination vaccines
- North America dominated the vaccine market with the largest revenue share of 38.3% in 2024, characterized by well-established healthcare infrastructure, high vaccination coverage, and strong support for innovation from both public agencies and biotech firms, with the U.S. witnessing a rise in adult and booster vaccinations driven by policy incentives and awareness campaigns
- Asia-Pacific is expected to be the fastest growing region in the vaccine market during the forecast period due to population growth, expanding healthcare access, and growing investment in domestic vaccine production capabilities
- The pediatric vaccine segment dominated the vaccine market with a market share of 46.1% in 2024, driven by mandatory immunization schedules and government-supported childhood vaccination programs across multiple countries
